Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
As of today, no completed, published, randomized controlled human trial exists for BPC-157 in any indication
(2020) suggested that MOTS-c could suppress the growth of colorectal cancer cells, indicating its potential as a therapeutic agent in cancer treatment.: While the research on MOTS-c is still in its early stages, the findings so far are promising
Early animal studies showed promising results, with obese mice losing significant body fat without changes in food intake or lean muscle mass
Cancer survivorship has seen the rise of an important co-endpoint in the ability to maintain fertility potential after treatment
US$ 20.76
US$ 27.95
US$ 22.85
US$ 27.58
US$ 29.35
US$ 26.69
US$ 23.34
